Antengene

Antengene, a Pharmaceutical Preparation Manufacturing company headquartered in China, reported total Scope 1 and Scope 2 emissions of approximately 1,169,980 kg CO2e for 2023. This includes about 45,220 kg CO2e from Scope 1 emissions and 1,124,760 kg CO2e from Scope 2 emissions.

In 2022, their Scope 1 and Scope 2 emissions were approximately 1,613,260 kg CO2e, comprising about 551,320 kg CO2e from Scope 1 and 1,061,940 kg CO2e from Scope 2. For 2021, the company's Scope 1 and Scope 2 emissions totalled approximately 994,380 kg CO2e, with Scope 1 at about 27,080 kg CO2e and Scope 2 at around 967,300 kg CO2e. In 2020, Antengene's Scope 1 and Scope 2 emissions were approximately 278,470 kg CO2e, including about 27,080 kg CO2e from Scope 1 and 251,390 kg CO2e from Scope 2.

Antengene has disclosed Scope 1 and Scope 2 emissions but has not reported Scope 3 emissions data. The company has not set any specific reduction targets, including SBTi-validated targets, nor has it signed up to the Climate Pledge.